Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
LATEST IN amyloid-β protein
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
UMSL hosts Greek community celebration of ‘KYKLOS – Circle of Glory’
The Hellenic Spirit Foundation pushed for the creation of the mural by St. Louis artist Rip Kastaris ahead of the 2004 Olympic Games, and it still hangs in the Olympic stadium in Athens.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
MORE IN amyloid-β protein
LATEST NEWS
- UMSL hosts Greek community celebration of ‘KYKLOS – Circle of Glory’
- Associate Professor Carissa Philippi presents on understanding depression and trauma through the brain as part of NextGen Precision Health’s Discovery Series
- Newly renovated University Libraries ready to support students in their quest for knowledge and career success
- Opportunity Scholar Nadia Manushev pursues career in optometry through the Department of Biology’s 3+4 program
- At Greater St. Louis, Inc., UMSL alum Kylee Garretson attracts companies to invest in St. Louis
- UMSL’s Advanced Workforce Center delivers diverse pathways to prepare the workforce of tomorrow
- Eye on UMSL: Banging the drum for peace
- College of Nursing hosts escape room simulation focused on infection prevention training
- New NextGen Leaders program aims to prepare students to become changemakers in their communities
- UMSL Innovation Center celebrates official grand opening
